Medifocus (CVE:MFS) Sets New 12-Month Low at $0.02

Shares of Medifocus Inc. (CVE:MFS) reached a new 52-week low during mid-day trading on Tuesday . The company traded as low as C$0.02 and last traded at C$0.02, with a volume of 5600 shares traded. The stock had previously closed at C$0.02.

The company has a market capitalization of $2.78 million and a P/E ratio of -2.14. The company has a 50-day moving average price of C$0.02.

About Medifocus (CVE:MFS)

Medifocus Inc, a medical technology company, develops and commercializes minimally invasive focused heat systems for the treatment of cancerous and benign tumors, and enlarged prostate in Canada and the United States. The company owns technology platforms, including Endo-thermotherapy platform, a catheter-based focused heat technology platform that utilizes natural body openings to deliver microwave thermotherapy to the diseased sites; and Adaptive Phased Array (APA) Microwave Focusing platform, which directs focused microwave energy at tumor center to induce shrinkage or eradication of tumors without undue harm to surrounding tissue.

Further Reading: Do back-end load funds outperform no-load funds?

Receive News & Ratings for Medifocus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medifocus and related companies with MarketBeat.com's FREE daily email newsletter.